|
09 Feb 2012
HOME
Pharma/CDC on Brain
damage from vaccines, Fauci, Phages, Bioweapons manufacture
HHS.gov is
Incompetent; BMJ calls fraud "crime.")
Official: CFIDS and MS-Lyme are the
same disease; Epstein-Barr
CDC Greed
(won't answer the FOIA)
ELISA = arbitrary cutoff.
Disclaimer
Overview
TUSKEGEE - By Jerry Leonard
1998, CIA Oilmen & Israelis plan to overthrow
Saddam for the oil.
Bush/Gore Oil/War-(Oct,2000)
Bush's own explainer (Oct
2000):
Iraq Oil
Iraq was an oil-theft war.
| |
Microbiologist, Spirochetologist
US PATENT
4,721,617
| United States Patent
|
|
| Johnson
|
January 26, 1988
|
Vaccine against lyme
disease
Abstract
A vaccine for the immunization of
mammals against Lyme borreliosis (Lyme
disease) is disclosed which contains an
effective amount of inactivated Borrelia burgdorferi spirochetes
dispersed in a
physiologically-acceptable, non-toxic
liquid vehicle.
| Inventors: |
Johnson; Russell C. (St. Paul,
MN) |
| Assignee: |
Regents of the University of
Minnesota (Minneapolis, MN) |
| Appl. No.:
|
896665 |
| Filed: |
August 14, 1986 |
BACKGROUND OF THE INVENTION
Lyme borreliosis (Lyme disease and
related disorders) is a zoonosis
characterized by a number of variable
syndromes. The etiological agent of this
disease is the spirochete Borrelia
burgdorferi, which is primarily
transmitted by Ixodes ticks. The
northern deer tick, Ixodes dammini is
the major vector of Lyme disease in
Minnesota, Wisconsin, the northeastern
United States and adjacent Canada. The
California black-legged tick, I.
pacificus is the primary vector of this
disease in the western United States,
and in Europe the major vector of Lyme
borreliosis is I. ricinus. The
spirochete has also been found in
deerflies, horseflies and mosquitos. The
preferred hosts for the larval and
nymphal stages of these ticks are small
rodents such as Peromyscus leucopus, the
white-footed mouse, whereas the adult
ticks preferentially feed on large
mammals, such as deer. Since
transovarial transmission of the
spirochetes by these ticks occurs
infrequently, the disease is transmitted
by the nymphal and adult ticks. The
frequent isolation of B. burgdorferi
from white-footed mice captured in foci
of Lyme disease suggests that small
rodents may serve as a natural reservoir
for this spirochete and source of
infection for the larval and/or nymphal
stages of the tick. Local spread of the
Ixodes ticks is by mammalian hosts, and
birds may serve an important role in
long distance tick dispersal.
Most cases of Lyme disease occur in June
or July, when the aggressive nymphal
stage is most active. As many as
two-thirds of the people that become
infected by this spirochete are unaware
of the tick bite because of the painless
bite and the small size (several mm) of
the nymphal stage.
Spirochetes are introduced into the host
at the site of the tick bite and this is
also the location of the initial
characteristic skin lesion, erythema
chronicum migrans (ECM). A systemic
illness ensues due to the lymphatic and
hematogenous spread of B. burgdorferi.
The early phase of the illness often
consists of the ECM, headache, fatigue,
muscle and joint aches, stiff neck and
chills and fever. This phase of the
disease may be followed by neurologic,
joint or cardiac abnormalities. The
chronic forms of the disease such as
arthritis (joint involvement),
acrodermatitis chronica atrophicans
(skin involvement), and Bannwart's
syndrome (neurological involvement) may
last for months to years and are
associated with the persistence of the
spirochete. A case of maternal-fetal
transmission of B. burgdorferi resulting
in neonatal death has been reported.
Domestic animals such as the dog also
develop arthritis and lameness to this
tick-borne infection. For every
symptomatic infection, there is at least
one asymptomatic infection. Lyme disease
is presently the most commonly reported
tick-borne disease in the United States.
The infection may be treated at
any time with antibiotics such as
penicillin, erythromycin, tetracycline,
and ceftriaxone. Once infection has
occurred, however, the drugs may not
purge the host of the spirochete but may
only act to control the chronic forms of
the disease. Complications such as
arthritis and fatigue may continue for
several years after diagnosis and
treatment.
Since the effectiveness of the present
methods of treatment are limited, and
vector control is impractical at best, a
need exists for a vaccine which is
effective to immunize high-risk
individuals and susceptible domestic
animals against Lyme borreliosis.
|